Liver cancer is one of the leading causes of cancer mortality worldwide. Hepatocellular carcinoma (HCC) is the main type of liver cancer. We applied a machine learning approach with maximum-relevance–minimum-redundancy (mRMR) algorithm followed by incremental feature selection (IFS) to a set of microarray data generated from 43 tumor and 52 nontumor samples. With the machine learning approach, we identified 117 gene probes that could optimally separate tumor and nontumor samples. These genes not only include known HCC-relevant genes such as MT1X, BMI1, and CAP2, but also include cancer genes that were not found previously to be closely related to HCC, such as TACSTD2. Then, we constructed a molecular interaction network based on the protein–protein interaction (PPI) data from the STRING database and identified 187 genes on the shortest paths among the genes identified with the machine learning approach. Network analysis reveals new potential roles of ubiquitin C in the pathogenesis of HCC. Based on gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, we showed that the identified subnetwork is significantly enriched in biological processes related to cell death. These results bring new insights of understanding the process of HCC.
Get full access to this article
View all access options for this article.
References
1.
BignottiE., TodeschiniP., CalzaS., et al.2010. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur. J. Cancer, 46, 944–953.
2.
BogdanovP., and SinghA.K.2010. Molecular function prediction using neighborhood features. IEEE/ACM Trans. Comput. Biol. Bioinform., 7, 208–217.
3.
ChatooW., AbdouhM., DavidJ., et al.2009. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J. Neurosci., 29, 529–542.
4.
ChenZ.J.2005. Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol., 7, 758–765.
5.
CherianM.2003. Metallothioneins in human tumors and potential roles in carcinogenesis. Mut. Res., 533, 201–209.
6.
ChouK.-C.1995. Prediction of protein structural classes. Biochem. Mol. Biol., 30, 275–349.
7.
ChouK.C.2011. Some remarks on protein attribute prediction and pseudo amino acid composition. J. Theor. Biol., 273, 236–247.
8.
ChouK.C., and ShenH.B.2006. Predicting eukaryotic protein subcellular location by fusing optimized evidence-theoretic k-nearest neighbor classifiers. J. Proteome Res., 5, 1888–1897.
9.
ChouK.C., and ShenH.B.2008. Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms. Nat. Protoc., 3, 153–162.
10.
Chris DingH.P.2005. Minimum redundancy feature selection from microarray gene expression data. J. Bioinform. Comput. Biol., 3, 185–205.
11.
De JayN., Papillon-CavanaghS., OlsenC., et al.2013. mRMRe: an R package for parallelized mRMR ensemble feature selection. Bioinformatics, 29, 2365–2368.
12.
DijkstraE.W.1959. A note on two problems in connexion with graphs. Num. Math., 1, 269–271.
13.
DziegielP., ForgaczJ., and SuderE., et al.2003. Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinoma of large intestine. Histol. Histopathol., 18, 401–407.
14.
El-SeragH.B., and RudolphK.L.2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557–2576.
15.
FongD., MoserP., KrammelC., et al.2008a. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br. J. Cancer, 99, 1290–1295.
16.
FongD., SpizzoG., GostnerJ.M., et al.2008b. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod. Pathol., 21, 186–191.
17.
GarrettS.H., SensM.A., and ShuklaD., et al.2000. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer. Prostate, 43, 125–135.
18.
GouldingH., JasaniB., PereiraH., et al.1995. Metallothionein expression in human breast cancer. Br. J. Cancer, 72, 968–972.
19.
HuangT., CuiW., HuL., et al.2009. Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles. PloS ONE, 4, e8126.
20.
Huang daW., ShermanB.T., and LempickiR.A.2009a. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1–13.
21.
Huang daW., ShermanB.T., and LempickiR.A.2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44–57.
22.
Jaromir GumulecM.R., VojtechA., ReneK., and MichalM.2014. Metallothionein–immunohistochemical cancer biomarker: a meta-analysis. PloS ONE, 9, e85346.
23.
JayasuryaA., BayB.H., YapW.M., et al.2000. Proliferative potential in nasopharyngeal carcinoma: correlation with metallothionein expression and tissue zinc levels. Carcinogenesis, 21, 1809–1812.
24.
JemalA., BrayF., CenterM.M., et al.2011. Global cancer statistics. CA Cancer J. Clin., 61, 69–90.
25.
JinR., BayB.H., ChowV.T., and TanP.H.2001. Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma. Breast Cancer Res. Treat., 66, 265–272.
26.
JosephM.G., BanerjeeD., KochaW., et al.2001. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome. Cancer, 92, 836–842.
27.
KaraozU., MuraliT.M., LetovskyS., et al.2004. Whole-genome annotation by using evidence integration in functional-linkage networks. Proc. Natl. Acad. Sci. USA, 101, 2888–2893.
28.
KourmpetisY.A.I., van DijkA.D.J., BinkM.C.A.M., et al.2010. Bayesian Markov random field analysis for protein function prediction based on network data. PloS ONE, 5, e9293.
29.
LetovskyS., and KasifS.2003. Predicting protein function from protein/protein interaction data: a probabilistic approach. Bioinformatics, 19, i197–i204.
30.
LiB.Q., ZhangJ., HuangT., et al.2012. Identification of retinoblastoma related genes with shortest path in a protein-protein interaction network. Biochimie, 94, 1910–1917.
31.
LlovetJ.M., BurroughsA., and BruixJ.2003. Hepatocellular carcinoma. Lancet, 362, 1907–1917.
32.
MuhlmannG., SpizzoG., GostnerJ., et al.2009. TROP2 expression as prognostic marker for gastric carcinoma. J. Clin. Pathol., 62, 152–158.
33.
NabievaE., JimK., AgarwalA., et al.2005. Whole-proteome prediction of protein function via graph-theoretic analysis of interaction maps. Bioinformatics, 21Suppl 1, i302–i310.
34.
NarteyN.O., BanerjeeD., and CherianM.G.1987a. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of fetal human liver and kidney and its changes during development. Pathology, 19, 233–238.
35.
NarteyN., CherianM.G., and BanerjeeD.1987b. Immunohistochemical localization of metallothionein in human thyroid tumors. Am. J. Pathol., 129, 177–182.
36.
NeoS.Y., LeowC.K., VegaV.B., et al.2004. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology, 39, 944–953.
37.
NgK.L., CiouJ.S., and HuangC.H.2010. Prediction of protein functions based on function-function correlation relations. Comput. Biol. Med., 40, 300–305.
38.
PengB., GuY., XiongY., et al.2012. Microarray-assisted pathway analysis identifies MT1X & NFkappaB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma. PloS ONE, 7, e51413.
39.
RipaniE., SacchettiA., CordaD., and AlbertiS.1998. Human TROP-2 is a tumor-associated calcium signal transducer. Int. J. Cancer, 76, 671–676.
40.
SchmidK.W., EllisI., GeeJ.M., et al.1993. Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch. A Pathol. Anat. Histopathol., 422, 153–159.
41.
SharanR., UlitskyI., and ShamirR.2007. Network-based prediction of protein function. Mol. Syst. Biol., 3, 88.
42.
ShibataR., MoriT., DuW., et al.2006. Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin. Cancer Res., 12, 5363–5368.
43.
SmootM.E., OnoK., RuscheinskiJ., et al.2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics, 27, 431–432.
44.
StuderR., VogtC.P., CavigelliM., et al.1997. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem. J., 328, 63–67.
45.
SzklarczykD., FranceschiniA., KuhnM., et al.2011. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561–D568.
46.
TanY., SinniahR., BayB.H., and SinghG.1999. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours. J. Pathol., 189, 60–65.
47.
TaoX., ZhengJ.M., XuA.M., et al.2007. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol. Res., 37, 820–827.
48.
TrerotolaM., CantanelliP., GuerraE., et al.2013. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene, 32, 222–233.
49.
TsuchiyaM., ParkerJ.S., KonoH., et al.2010. Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma. Mol. Cancer, 9, 74.
50.
WangH., PanK., ZhangH.K., et al.2008a. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol., 134, 535–541.
51.
WangJ., DayR., DongY., et al.2008b. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol. Cancer Ther., 7, 280–285.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
